Rescue analgesic consumption · patients with pain in Guillain‐Barré syndrome
It is very uncertain whether carbamazepine changes rescue analgesic consumption compared with placebo (very low certainty).
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · patients with pain in Guillain‐Barré syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients with pain in Guillain‐Barré syndrome
1 finding from 1 review
Sedation score (numerical rating scale of 1 to 6: 0 = anxious, agitated, or restless, 6 = asleep, no response) · patients with pain in Guillain‐Barré syndrome
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · intensive care unit in India
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · intensive care unit in India
1 finding from 1 review
no estimate extracted
24 participants
Very low
Sedation score (numerical rating scale of 1 to 6: 0 = anxious, agitated, or restless, 6 = asleep, no response) · intensive care unit in India
1 finding from 1 review
no estimate extracted
24 participants
Very low
Rescue analgesic consumption · intensive care unit in India
It is very uncertain whether gabapentin changes rescue analgesic consumption compared with carbamazepine (very low certainty).
1 finding from 1 review
no estimate extracted
24 participants
Very low
Immediate improvement in pain relief Number of participants improved (good/very good efficacy) on a self assessed categorical 'overall efficacy score' (0 = no efficacy to 4 = very good) · patients with trigeminal neuralgia
Tizanidine showed no clear difference in immediate improvement in pain relief Number of participants improved… compared with carbamazepine (low certainty).
1 finding from 1 review
Relief of pain · patients with trigeminal neuralgia
1 finding from 1 review
Reduction in pain intensity · patients with trigeminal neuralgia
1 finding from 1 review
Quality of life assessment 12 weeks after the start of treatment Not measured · patients with trigeminal neuralgia
1 finding from 1 review
Adverse effects The number of participants with adverse effects · patients with trigeminal neuralgia
1 finding from 1 review
Reduction in pain intensity · patients with trigeminal neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life assessment 12 weeks after the start of treatment Not measured · patients with trigeminal neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (not reported) · patients with trigeminal neuralgia
1 finding from 1 review
Relief of pain · patients with trigeminal neuralgia
1 finding from 1 review
Reduction in pain intensity · patients with trigeminal neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life assessment 12 weeks after the start of treatment Not measured · patients with trigeminal neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · patients with trigeminal neuralgia
1 finding from 1 review